PRODUCT
Summary
MIP1 beta peptide is used for blocking the activity of MIP1 beta antibody (catalog number GTX17201).
APPLICATION
Application Note
*Optimal dilutions/concentrations should be determined by the researcher.
Application |
Recommended Dilution |
Assay dependent |
Not tested in other applications.
PROPERTIES
Form
Liquid
Buffer
PBS, 0.1% BSA
Preservative
0.02% Sodium azide
Storage
Store as concentrated solution. Aliquot and store at -20ºC or below. Avoid freeze-thaw cycles.
Concentration
200 μg/ml (Please refer to the vial label for the specific concentration.)
Conjugation
Unconjugated
Note
For laboratory research use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.
Purchasers shall not, and agree not to enable third parties to, analyze, copy, reverse engineer or otherwise attempt to determine the structure or sequence of the product.
TARGET
Synonyms
C-C Motif Chemokine Ligand 4 , Act2 , At744.1 , G-26 , Hc21 , Lag-1 , Lag1 , Mip-1-Beta , Mip1B , Mip1B1 , Scya2 , Scya4 , Ccl4
Background
The protein encoded by this gene is a mitogen-inducible monokine and is one of the major HIV-suppressive factors produced by CD8+ T-cells. The encoded protein is secreted and has chemokinetic and inflammatory functions. [provided by RefSeq, Dec 2012]
Research Area
REFERENCE
There are currently no references for MIP1 beta blocking peptide (GTX17201-PEP). Be the first to share your publications with this product.
REVIEW
There are currently no reviews for MIP1 beta blocking peptide (GTX17201-PEP). Be the first to share your experience with this product.